Company news
Brii Biosciences Limited news in 2026
Brii Biosciences Limited's news releases, calls and decks from 2026, newest first.
VOLUNTARY ANNOUNCEMENT Presents Late-Breaking Data from Phase 2 ENRICH and ENHANCE Studies at AASLD 2026
November 5, 2026
Monthly return of equity issuer on movements in securities for the month ended 31 October 2026
November 5, 2026
Next Day Disclosure Return
November 4, 2026
Next Day Disclosure Return
November 3, 2026
Next Day Disclosure Return
November 2, 2026
Next Day Disclosure Return
October 30, 2026
Next Day Disclosure Return
October 29, 2026
Next Day Disclosure Return
October 28, 2026
Next Day Disclosure Return
October 27, 2026
Next Day Disclosure Return
October 26, 2026
Next Day Disclosure Return
October 23, 2026
Next Day Disclosure Return
October 22, 2026
Next Day Disclosure Return
October 21, 2026
Next Day Disclosure Return
October 20, 2026
Next Day Disclosure Return
October 16, 2026
VOLUNTARY ANNOUNCEMENT Launch of BRiSC, an siRNA Therapeutics Discovery Platform
October 15, 2026
Next Day Disclosure Return
October 14, 2026
Next Day Disclosure Return
October 13, 2026
Next Day Disclosure Return
October 12, 2026
Next Day Disclosure Return
October 9, 2026
Grant of share options and restricted share units
October 8, 2026
Monthly return of equity issuer on movements in securities for the month ended 30 September 2026
October 7, 2026
Notification Letter and Request Form for Non-registered Shareholders
September 17, 2026
Notification Letter and Change Request Form for Registered Shareholders
September 17, 2026
2026 Interim Report
September 17, 2026
Brii Biosciences Provides Corporate Updates and Reports 2026 Interim Financial Results
August 20, 2026
Brii Bio Announces Topline End-of-Treatment Data from Phase 2b ENRICH and ENHANCE Studies for the Treatment of Chronic Hepatitis B
July 2, 2026
Brii Bio Presents Late-Breaking Data from Its Phase 2 ENSURE Study at EASL Congress 2026, Further Supporting the Potential Role of BRII-179 in Achieving Durable Immunological Control of HBV
May 27, 2026
Brii Bio Presents Cross-Study Analysis of Post-Treatment HBsAg Rebound at APASL 2026
April 26, 2026
Brii Biosciences Provides Corporate Updates and Reports Full Year 2025 Financial Results
March 19, 2026
Decks in 2026
- Investor Presentation (October 2026)
Investor deck · 29 slides · October 2026